Compare Citius Pharmaceuticals Inc (CTXR) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs PulteGroup, Inc. — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while PulteGroup, Inc. trades at $132.77 (market cap $25.22B). The key difference: PulteGroup, Inc. is far larger — about 1260.4× Citius Pharmaceuticals Inc's market cap, and PulteGroup, Inc. pays a 0.79% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | PHM | |
|---|---|---|
Market Cap | $20.01M | $25.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $142.56 |
52-Week Low | $0.48 | $110.11 |
Enterprise Value | $16.23M | $25.64B |
Dividend Yield | — | 0.79% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
